omega-n-methylarginine has been researched along with copper bis(3,5-diisopropylsalicylate) in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (copper bis(3,5-diisopropylsalicylate)) | Trials (copper bis(3,5-diisopropylsalicylate)) | Recent Studies (post-2010) (copper bis(3,5-diisopropylsalicylate)) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 62 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boileau, C; Jouzeau, JY; Nedelec, E; Netter, P; Pacquelet, S; Presle, N; Terlain, B | 1 |
1 other study(ies) available for omega-n-methylarginine and copper bis(3,5-diisopropylsalicylate)
Article | Year |
---|---|
Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1.
Topics: Animals; Cartilage Diseases; Cartilage, Articular; Cells, Cultured; Chondrocytes; Depression, Chemical; Enzyme Inhibitors; Free Radical Scavengers; Humans; Interleukin-1; Interleukin-17; Male; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Proteoglycans; Rats; Rats, Wistar; Salicylates | 2002 |